Understanding the role of rs6983267 in cancer can have several clinical implications:
- Risk Assessment: Identifying individuals who carry the risk allele of rs6983267 can help in assessing their cancer risk, enabling more personalized and proactive healthcare strategies. - Targeted Therapies: Insights into how rs6983267 influences MYC expression could lead to the development of targeted therapies aimed at modulating this pathway, potentially offering new treatment options for patients with cancers linked to this SNP. - Preventive Measures: For individuals with a high genetic risk due to rs6983267, preventive measures such as regular screenings and lifestyle modifications could be recommended to reduce their overall risk of developing cancer.
